Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
APRE
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -57.6%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
therapeutics
aprea
gained
after
close
2023
announced
jumped
cancer
nyse
clinical
results
focused
today
synthetic
lethality
inhibitor
globe
newswire
A
APRE
Aprea Therapeutics, Inc. Common stock
Stonvex
StonvexStonvexStonvexStonvex